Google
 
Web www.vitaminlore.com
www.eniva.com

Lamivudine

Also indexed as: 3TC, Epivir®

Combination drug: Combivir®

Lamivudine is used to treat human immunodeficiency virus (HIV) infection and is in a class of drugs known as antivirals.

Interactions with Herbs

Sho-saiko-to
Test tube studies show that the herbal combination sho-saiko-to enhances the antiviral activity of lamivudine.1 Sho-saiko-to contains extracts of seven herbs, including Bupleuri radix, Pinelliae tuber, Scutellariae radix, Zizyphi fructus, ginseng (Ginseng radix),licorice (Glycyrrhizae radix), and ginger (Zingibers rhizoma). Controlled studies are needed to determine whether taking sho-saiko-to might enhance the beneficial effects of lamivudine.

Summary of Interactions for Lamivudine

Depletion or interference None known
Adverse interaction None known
Side effect reduction/prevention None known
Supportive interaction Sho-saiko-to*
Reduced drug absorption/bioavailability None known

For the convenience of the reader, the information in the summary is categorized as follows: “Depletion or interference” indicates the drug may deplete or interfere with the absorption or function of the supplement or herb. “Adverse interaction” indicates that the supplement or herb used together with the drug may result in undesirable effects. “Side effect reduction/prevention” indicates the supplement or herb may reduce the likelihood and/or severity of a potential side effect caused by the drug. “Supportive interaction” indicates the supplement or herb may support or aid the function of the drug. “Reduced drug absorption/bioavailability” indicates that the supplement or herb may decrease the absorption and/or activity of the drug in the body. An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

References:

1. Piras G, Makino M, Baba M. Sho-saiko-to, a traditional kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro. Microbiol Immunol 1997;41:835–9.